Zhang H, Li Q, Liao Y, Ma D, Zeng F, Zhang Z
Int J Mol Sci. 2025; 25(24.
PMID: 39769249
PMC: 11678876.
DOI: 10.3390/ijms252413486.
Bai L, Xu J, Zeng L, Zhang L, Zhou F
Mol Biomed. 2024; 5(1):35.
PMID: 39207577
PMC: 11362470.
DOI: 10.1186/s43556-024-00199-7.
Pei L, Hickman H
Viruses. 2024; 16(5).
PMID: 38793562
PMC: 11126121.
DOI: 10.3390/v16050679.
Velusamy T, Singh N, Croft S, Smith S, Tscharke D
J Virol. 2023; 97(11):e0110723.
PMID: 37902400
PMC: 10688380.
DOI: 10.1128/jvi.01107-23.
Sharma D, Sharma S, Akojwar N, Dondulkar A, Yenorkar N, Pandita D
Vaccines (Basel). 2023; 11(2).
PMID: 36851084
PMC: 9966607.
DOI: 10.3390/vaccines11020206.
Osteopontin contributes to virus resistance associated with type I IFN expression, activation of downstream ifn-inducible effector genes, and CCR2CD115CD206 macrophage infiltration following ocular HSV-1 infection of mice.
Filiberti A, Gmyrek G, Berube A, Carr D
Front Immunol. 2023; 13:1028341.
PMID: 36685562
PMC: 9846535.
DOI: 10.3389/fimmu.2022.1028341.
Good cop, bad cop: Polyamines play both sides in host immunity and viral replication.
Cruz-Pulido Y, Mounce B
Semin Cell Dev Biol. 2023; 146:70-79.
PMID: 36604249
PMC: 10101871.
DOI: 10.1016/j.semcdb.2022.12.004.
Persistent Herpes Simplex Virus Type 1 Infection of Enteric Neurons Triggers CD8 T Cell Response and Gastrointestinal Neuromuscular Dysfunction.
Brun P, Conti J, Zatta V, Russo V, Scarpa M, Kotsafti A
Front Cell Infect Microbiol. 2021; 11:615350.
PMID: 34094993
PMC: 8169984.
DOI: 10.3389/fcimb.2021.615350.
Vaccines against Genital Herpes: Where Are We?.
Kim H, Lee H
Vaccines (Basel). 2020; 8(3).
PMID: 32727077
PMC: 7566015.
DOI: 10.3390/vaccines8030420.
Resolution of herpes simplex virus reactivation in vivo results in neuronal destruction.
Doll J, Hoebe K, Thompson R, Sawtell N
PLoS Pathog. 2020; 16(3):e1008296.
PMID: 32134994
PMC: 7058292.
DOI: 10.1371/journal.ppat.1008296.
Herpes Simplex Virus Latency Is Noisier the Closer We Look.
Singh N, Tscharke D
J Virol. 2019; 94(4).
PMID: 31776275
PMC: 6997768.
DOI: 10.1128/JVI.01701-19.
A new era in cytomegalovirus vaccinology: considerations for rational design of next-generation vaccines to prevent congenital cytomegalovirus infection.
Nelson C, Herold B, Permar S
NPJ Vaccines. 2018; 3:38.
PMID: 30275984
PMC: 6148244.
DOI: 10.1038/s41541-018-0074-4.
Effects of spatiotemporal HSV-2 lesion dynamics and antiviral treatment on the risk of HIV-1 acquisition.
Byrne C, Gantt S, Coombs D
PLoS Comput Biol. 2018; 14(4):e1006129.
PMID: 29698393
PMC: 5940244.
DOI: 10.1371/journal.pcbi.1006129.
Increasing antigen presentation on HSV-1-infected cells increases lesion size but does not alter neural infection or latency.
Russell T, Velusamy T, Tseng Y, Tscharke D
J Gen Virol. 2018; 99(5):682-692.
PMID: 29620508
PMC: 5994700.
DOI: 10.1099/jgv.0.001059.
Laser Adjuvant-Assisted Peptide Vaccine Promotes Skin Mobilization of Dendritic Cells and Enhances Protective CD8 T and T Cell Responses against Herpesvirus Infection and Disease.
Lopes P, Todorov G, Pham T, Nesburn A, Bahraoui E, BenMohamed L
J Virol. 2018; 92(8).
PMID: 29437976
PMC: 5874417.
DOI: 10.1128/JVI.02156-17.
Effective Priming of Herpes Simplex Virus-Specific CD8 T Cells Does Not Require Infected Dendritic Cells.
Whitney P, Makhlouf C, MacLeod B, Ma J, Gressier E, Greyer M
J Virol. 2017; 92(3).
PMID: 29142130
PMC: 5774880.
DOI: 10.1128/JVI.01508-17.
Systems-guided forward genetic screen reveals a critical role of the replication stress response protein ETAA1 in T cell clonal expansion.
Miosge L, Sontani Y, Chuah A, Horikawa K, Russell T, Mei Y
Proc Natl Acad Sci U S A. 2017; 114(26):E5216-E5225.
PMID: 28607084
PMC: 5495275.
DOI: 10.1073/pnas.1705795114.
Dok-1 and Dok-2 Are Required To Maintain Herpes Simplex Virus 1-Specific CD8 T Cells in a Murine Model of Ocular Infection.
Lahmidi S, Yousefi M, Dridi S, Duplay P, Pearson A
J Virol. 2017; 91(15).
PMID: 28490594
PMC: 5512252.
DOI: 10.1128/JVI.02297-16.
Immune response of T cells during herpes simplex virus type 1 (HSV-1) infection.
Zhang J, Liu H, Wei B
J Zhejiang Univ Sci B. 2017; 18(4):277-288.
PMID: 28378566
PMC: 5394093.
DOI: 10.1631/jzus.B1600460.
IL-2 complex treatment amplifies CD8 T cell mediated immunity following herpes simplex virus-1 infection.
Rajasagi N, Rouse B
Microbes Infect. 2016; 18(12):735-746.
PMID: 27866863
PMC: 5182080.
DOI: 10.1016/j.micinf.2016.10.010.